Skip to main content

Enzeevu News

Intraocular Inflammation More Common With Aflibercept Injections in Real-World Setting

FRIDAY, May 9, 2025 – The incidence of mild intraocular inflammation (IOI) in the real world occurs more frequently after intravitreal injection of aflibercept than in clinical trials, according to...

Monthly News Roundup - August 2024

FDA Clears Pfizer and Moderna 2024-2025 COVID-19 mRNA Vaccines  On August 22, the FDA approved the latest COVID-19 mRNA monovalent vaccines from Moderna (Spikevax) and Pfizer / BioNTech (Comirnaty) ...

FDA Approves Enzeevu (aflibercept-abzv), a Biosimilar to Eylea

Basel, August 12, 2024 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, today announced that the US Food and Drug Administration (FDA) has approved Enzeevu (...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Macular Degeneration

Enzeevu patient information at Drugs.com